Development of bioassays using the zebrafish larva model to screen endocrine disruptors for their involvement in the pathological progression of non-alcoholic fatty liver diseases - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Toxicology Letters Année : 2022

Development of bioassays using the zebrafish larva model to screen endocrine disruptors for their involvement in the pathological progression of non-alcoholic fatty liver diseases

Fichier non déposé

Dates et versions

hal-03799000 , version 1 (05-10-2022)

Identifiants

Citer

H. Le Mentec, A. Legrand, E. Monniez, M. Bescher, D Lagadic-Gossmann, et al.. Development of bioassays using the zebrafish larva model to screen endocrine disruptors for their involvement in the pathological progression of non-alcoholic fatty liver diseases. Toxicology Letters, 2022, 368, pp.S241-S242. ⟨10.1016/j.toxlet.2022.07.645⟩. ⟨hal-03799000⟩
19 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More